Volver a Agenda
Session Chair(s)
Alison Greene
Genentech, A Member of the Roche Group, United States
Learning Objective : Discuss the context and considerations for including biosensors in drug development trials; Manage the technical issues for successful implementation in a study; Describe the current landscape and status of biosensor use in clinical studies.
Speaker(s)
Rethinking Outcomes Assessments: Where Do Biosensors Fit in Drug Development?
Alison Greene
Genentech, A Member of the Roche Group, United States
Implementing New Technology in Clinical Trials: An Interesting Adventure
John Reites
THREAD, United States
Chief Executive Officer
¿Tiene una cuenta?